•
Jun 30, 2023

Sabra Health Care REIT Q2 2023 Earnings Report

Sabra Health Care REIT's performance in Q2 2023 reflected a strengthening portfolio driven by occupancy gains and easing labor pressures, alongside encouraging reimbursement trends.

Key Takeaways

Sabra Health Care REIT reported a net income of $0.09 per diluted common share for Q2 2023. The company's portfolio is strengthening due to occupancy gains and easing labor pressures.

Net Income was $0.09 per share.

FFO was $0.32 per share.

Normalized FFO was $0.33 per share.

AFFO was $0.33 per share.

Total Revenue
$161M
Previous year: $156M
+3.3%
EPS
$0.33
Previous year: $0.39
-15.4%
FFO per diluted share
$0.32
Previous year: $0.36
-11.1%
Normalized FFO per diluted share
$0.33
Previous year: $0.39
-15.4%
AFFO per diluted share
$0.33
Previous year: $0.36
-8.3%
Gross Profit
$112M
Previous year: $117M
-4.0%
Cash and Equivalents
$27.2M
Previous year: $67.2M
-59.4%
Total Assets
$5.52B
Previous year: $5.96B
-7.3%

Sabra Health Care REIT

Sabra Health Care REIT

Sabra Health Care REIT Revenue by Segment

Forward Guidance

Sabra's portfolio is expected to continue strengthening as occupancy gains and easing labor pressures drive improved rent coverages. Reimbursement trends also remain encouraging, highlighted by Medicaid rate increases.

Revenue & Expenses

Visualization of income flow from segment revenue to net income